NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS
13
[4] Daluge, S. M.; Good, S. S.; Faletto, M. B.; Miller, W. H.; Clair, M. H. S.; Boone,
L. R.; Tisdale, M.; Parry, N. R.; Reardon, J. E.; Dornsife, R. E.; et al. Unique
Intracellular Activation of the Potent anti-Human Immunodeficiency Virus Agent
1592U89. Antimicrob. Agents Chemother. 1997, 41, 1099–1107.
[5] Hoshino, H.; Shimizu, N.; Shimada, N.; Takita, T.; Takeuchi, T. Inhibition of
Infectivity of Human Immunodeficiency Virus by Oxetanocin. J. Antibiot. 1987, 40,
1077–1078.
[6] (a) Bisacchi, G. S.; Braitman, A.; Cianci, C. W.; Clark, J. M.; Field, A. K.; Hagen,
M. E.; Hockstein, D. R.; Malley, M. F.; Mitt, T.; Slusarchyk, W. A.; et al. Synthesis
and Antiviral Activity of Enantiomeric Forms of Cyclobutyl Nucleoside Analogs. J.
Med. Chem. 1991, 34, 1415–1421; (b) Bisacchi, G. S.; Singh, J.; Godfrey, J. D., Jr.;
Kissick, T. P.; Mitt, T.; Malley, M. F.; Marco, J. D.; Gougoutas, J. Z.; Mueller, R. H.;
Zahler, R. Regioselective Coupling of Tetraalkylammonium Salts of 6-Iodo-2-
Aminopurine to a Cyclobutyl Triflate: Efficient Preparation of Homochiral BMS-
180,194, a Potent Antiviral Carbocyclic Nucleoside. J. Org. Chem. 1995, 60,
2902–2905; (c) Singh, J.; Bisacchi, G. S.; Ahmad, S.; Godfrey, J. D., Jr.; Kissick, T. P.;
Mitt, T.; Kocy,O.; Vu, T.; Papaioannou, C.G.; Wong, M.K.; et al. A Practical
Asymmetric Synthesis of the Antiviral Agent Lobucavir, BMS-180194. Org. Process
Res. Dev. 1998, 2, 393–399; (d) Genovesi, E. V.; Lamb, L.; Medina, I.; Taylor, D.;
Seifer, M.; Innaimo, S.; Colonno, R. J.; Clark, J. M. Antiviral Efficacy of Lobucavir
(BMS-180194), a Cyclobutyl-Guanosine Nucleoside Analogue, in the Woodchuck
(Marmota monax) Model of Chronic Hepatitis B Virus (HBV) Infection. Anti Viral
Res. 2000, 48, 197–203; (e) Hanson, R. L.; Shi, Z.; Brzozowski, D. B.; Banerjee, A.;
Kissick, T. P.; Singh, J.; Pullockaran, A. J.; North, J. T.; Fan, J.; Howell, J.; Durand,
S.C.; et al. Regioselective Enzymatic Aminoacylation of Lobucavir to Give an
Intermediatefor Lobucavir Prodrug. Bioorg. Med. Chem. 2000, 8, 2681–2687; (f)
Darses, B.; Greene, A. E.; Coote, S. C.; Poisson, J. F. Expedient Approach to Chiral
Cyclobutanones: Asymmetric Synthesis of Cyclobut-G. Org. Lett. 2008, 10, 821–824.
[7] Lee-Ruff, E.; Mladenova, G. Enantiomerically Pure Cyclobutane Derivatives and
Their Use in Organic Synthesis. Chem. Rev. 2003, 103, 1449–1483.
[8] Lee-Ruff, E. Synthesis of Cyclobutanes. In Chemistry of Cyclobutanes, Rappoport, Z.,
Liebman, J. F. Eds.; Wiley: Chichester, UK, 2005; Vol. 1, pp 281–355.
[9] (a) Lee-Ruff, E.; Wells, D. Bicyclic Nucleoside Synthesis-A Photochemical Approach.
Nucleosides, Nucleotides Nucleic Acids. 2008, 27, 484–494; (b) Mladenova, G.; Lee-
Ruff, E. Cyclobutanone Photoadducts of HCN and Malononitrile: Useful
Intermediates for the Synthesis of C-Nucleosides. Tetrahedron Lett. 2007, 48,
2787–2789; (c) Ghazi, H.; Lee-Ruff, E. Synthesis of Fluorocyclobutanones and Their
Use in the Synthesis of Fluoronucleosides. J. Fl. Chem. 2005, 126, 1565–1569; (d)
Zhong, J. H.; Fishman, A.; Lee-Ruff, E. Photochemistry on Soluble Polymer
Supports: Synthesis of Nucleosides. Org. Lett. 2002, 4, 4415–4417; (e) Lee-Ruff, E.;
Wan, W.-Q.; Jiang, J.-L. A Novel Approach Toward the Synthesis of Chiral2,3-
Dideoxy Nucleosides and Their Carbocyclic Analogs. J. Org. Chem. 1994, 59,
2114–2118; (f) Lee-Ruff, E.; Xi, F.; Qie, J. H. Enantioselective Preparation of 2, 3
–Dideoxynucleosides and Their Analogs from Ring-Expansion of Cyclobutanones. 2.
Synthesis
of
2,
3
-Dideoxyribosides
and
(1S,3R)-1-Amino-3-
(Hydroxymethyl)Cyclopentane. J. Org. Chem. 1996, 61, 1547–1550; (g) Lee-Ruff, E.;
Ostrowski, M.; Ladha, A.; Stynes, D. V.; Vernik, I.; Jiang, J. L.; Wan, W. Q.; Ding,
S. F.; Joshi, S. Synthesis and HIV Inhibition Activity of 2, 3 –Dideoxy-3 -C-
Hydroxymethyl Nucleosides. J. Med. Chem. 1996, 39, 5276–5280; (h) Lee-Ruff, E.;